You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent GBM

Showing 1 - 25 of 8,102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial (Tofacitinib 5 MG)

Recruiting
  • Glioblastoma
  • Tofacitinib 10mg
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 3, 2023

Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

Not yet recruiting
  • Recurrent Glioblastoma
  • +2 more
  • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
  • Charlottesville, Virginia
    University of Virginia
Sep 10, 2023

Glioblastoma, Glioblastoma Multiforme Trial (APG-157)

Available
  • Glioblastoma
  • Glioblastoma Multiforme
  • (no location specified)
Sep 19, 2022

Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

Recruiting
  • Glioblastoma Multiforme
  • Recurrent Glioblastoma
  • TheraSphere GBM
  • San Francisco, California
  • +4 more
Aug 15, 2022

Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

Active, not recruiting
  • Glioblastoma Multiforme
  • Stanford, California
  • +1 more
Nov 22, 2022

Recurrent GBM Trial (SONALA-001 (ALA) and Exablate device)

Recruiting
  • Recurrent GBM
  • SONALA-001 (ALA) and Exablate device
  • Phoenix, Arizona
  • +2 more
Jan 6, 2023

Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days

Recruiting
  • Glioblastoma, Adult
  • Pembrolizumab at 7 days prior
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

Recruiting
  • Glioblastoma
  • +3 more
  • Radiation: Intra-operative Radiation Therapy - IORT
  • +2 more
  • Santa Monica, California
    Providence Saint John's Health Center
Jul 14, 2022

Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)

Active, not recruiting
  • Glioblastoma Multiforme
  • VBI-1901
  • +2 more
  • Los Angeles, California
  • +3 more
Jun 27, 2022

Recurrent Glioblastoma, Glioblastoma - Category Trial in Edmonton (Repeat Surgical Management of Recurrent GBM)

Recruiting
  • Recurrent Glioblastoma
  • Glioblastoma - Category
  • Repeat Surgical Management of Recurrent GBM
  • Edmonton, Alberta, Canada
    University of Alberta Division of Neurosurgery
Apr 5, 2022

Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

Active, not recruiting
  • Glioblastoma Multiforme of Brain
  • +2 more
  • C134
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 19, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • SonoCloud-9 (SC9)
  • +3 more
  • Chicago, Illinois
  • +7 more
Jun 5, 2023

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Recurrent Glioblastoma Trial (Sintilimab plus Bevacizumab and Temozolomide)

Not yet recruiting
  • Recurrent Glioblastoma
  • Sintilimab plus Bevacizumab and Temozolomide
  • (no location specified)
Nov 27, 2022

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Recurrent Glioblastoma Trial in San Francisco (Individualized therapy)

Recruiting
  • Recurrent Glioblastoma
  • Individualized therapy
  • San Francisco, California
    University of California San Francisco
Nov 2, 2021

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

Completed
Has Results
  • GBM
  • +3 more
  • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
  • Durham, North Carolina
    Duke University Medical Center
Jun 28, 2022

Glioblastoma, Recurrent Disease, Recurrent Glioblastoma Trial in Calgary (Afatinib, Dasatinib, Palbociclib)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Jun 24, 2022

Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioblastoma
  • +5 more
  • Los Angeles, California
  • +4 more
Apr 8, 2022

Recurrent Glioblastoma Trial in Portland (TVI-Brain 1)

Available
  • Recurrent Glioblastoma
  • TVI-Brain 1
  • Portland, Oregon
    Providence St. Vincent Medical Center
Jun 28, 2023

Glioblastoma Trial (5x10(7) CART-EGFR-IL13Ra2, 1x107 CART-EGFR-IL13Ra2, 1x10(8) CART-EGFR-IL13Ra2)

Not yet recruiting
  • Glioblastoma
  • 5x10(7) CART-EGFR-IL13Ra2
  • +5 more
  • (no location specified)
Jan 7, 2022

Glioblastoma Multiforme Trial in Australia, Austria, Netherlands (4-L-[131I]iodo-phenylalanine (131I-IPA))

Active, not recruiting
  • Glioblastoma Multiforme
  • 4-L-[131I]iodo-phenylalanine (131I-IPA)
  • Gateshead, New South Wales, Australia
  • +4 more
Nov 25, 2021

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022